Bausch Health Companies (BHC) EBT Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1,282.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -1,020.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2,093.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 396.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 856.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -258,655.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 944.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -156.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 17,296.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 856.00 |
| Mar 31, 2026 | -4,665.00 |
| Dec 31, 2025 | 1,828.00 |
| Sep 30, 2025 | -1,333.00 |
| Jun 30, 2025 | 1,209.00 |
| Mar 31, 2025 | 219.00 |
| Dec 31, 2024 | 721.00 |
| Sep 30, 2024 | -1,107.00 |
| Jun 30, 2024 | 3,390.00 |
| Mar 31, 2024 | 2,595.00 |
| Dec 31, 2023 | 1,751.00 |
| Sep 30, 2023 | -1,807.00 |
| Jun 30, 2023 | 2,991.00 |
| Mar 31, 2023 | 185.00 |
| Dec 31, 2022 | 4,982.00 |
| Sep 30, 2022 | 2,444.00 |
| Jun 30, 2022 | 176.00 |
| Mar 31, 2022 | 178.00 |
| Dec 31, 2021 | 2,104.00 |
| Sep 30, 2021 | 2,428.00 |